Icagen, Inc.·4

May 20, 6:16 PM ET

Icagen, Inc. 4

4 · Icagen, Inc. · Filed May 20, 2016

Insider Transaction Report

Form 4
Period: 2016-05-19
Krafte Douglas
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2016-05-19+100,000100,000 total
    Exercise: $3.50From: 2016-05-19Exp: 2026-05-19Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]These options vest as follows: 25,000 vest on June 30, 2016 and the remaining 75,000 vest pro rata on a monthly basis over a three year period.

Documents

1 file
  • 4
    f4051916kraft_icagen.xmlPrimary

    OWNERSHIP DOCUMENT